Acutus Medical Inc. has filed for an initial public offering, seeking to sell $75 million worth of shares to grow its medical-devices business. The Carlsbad, Calif., company makes imaging and other products and therapies related to heart rhythm disorders. J.P. Morgan, BofA Securities, and William Blair are among the underwriters. The company hopes to list its shares on the Nasdaq under the ticker AFIB. Acutus said its first-quarter sales rose to $1.6 million, from $787,000 in the first quarter of 2019. It lost $18.1 million, or $2.66 a share, in the quarter, compared with a loss of $14.7 million, or $2.30 a share, in the year-ago period, according to a filing on Wednesday.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.